Qube Research & Technologies (QRT)’s Utah Medical Products UTMD Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio UTMD Stock Details UTMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$364K	Sell	5,871 -9,403	-62%	-$592K	﹤0.01%	2826
2025 Q4	$855K	Buy	15,274 +1,786	+13%	+$104K	﹤0.01%	2618
2025 Q3	$849K	Buy	13,488 +948	+8%	+$56.1K	﹤0.01%	2579
2025 Q2	$714K	Sell	12,540 -728	-5%	-$39.6K	﹤0.01%	2581
2025 Q1	$744K	Sell	13,268 -799	-6%	-$47.9K	﹤0.01%	2388
2024 Q4	$865K	Buy	14,067 +4,343	+45%	+$281K	﹤0.01%	2238
2024 Q3	$651K	Buy	9,724 +4,117	+73%	+$279K	﹤0.01%	2185
2024 Q2	$375K	Buy	5,607 +1,004	+22%	+$68.3K	﹤0.01%	2231
2024 Q1	$327K	Buy	4,603 +3,590	+354%	+$269K	﹤0.01%	2767
2023 Q4	$85.3K	Buy	+1,013	New	+$84K	﹤0.01%	3152

Other funds holding UTMD

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Qube Research & Technologies (QRT)'s UTMD Position: Q1 2026 in Review

Qube Research & Technologies (QRT) reduced its Utah Medical Products (UTMD) stake by 62% in Q1 2026, selling an estimated $592K and leaving 5,871 shares worth $364K. The position accounts for ﹤0.01% of the portfolio, ranked #2826.

Qube Research & Technologies (QRT) first reported a position in UTMD in Q4 2023 and has held it in 10 quarters since. The position peaked at $865K in Q4 2024. 119 funds tracked by Wall St. Rank hold UTMD as of Q1 2026.

Qube Research & Technologies (QRT) held 5,871 shares of Utah Medical Products worth $364K as of Q1 2026.
Qube Research & Technologies (QRT) sold 9,403 Utah Medical Products shares in Q1 2026, an estimated $592K.
Utah Medical Products made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #2826 holding.
Qube Research & Technologies (QRT) first reported a position in Utah Medical Products in Q4 2023 and has held it in 10 quarters since.
Qube Research & Technologies (QRT)'s Utah Medical Products position peaked at $865K in Q4 2024.
119 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.